Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.

Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, Hoebe K, Panos RJ, Maxfield M, Glasser SW, Senft AP, Raulet DH, Borchers MT.

J Immunol. 2012 May 1;188(9):4468-75. doi: 10.4049/jimmunol.1102643. Epub 2012 Mar 30.

2.

TLR and NKG2D signaling pathways mediate CS-induced pulmonary pathologies.

Wortham BW, Eppert BL, Flury JL, Morgado Garcia S, Borchers MT.

PLoS One. 2013 Oct 9;8(10):e78735. doi: 10.1371/journal.pone.0078735. eCollection 2013.

3.

Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease.

Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, Wesselkamper SC, Borchers MT.

J Immunol. 2010 Apr 15;184(8):4460-9. doi: 10.4049/jimmunol.0903654. Epub 2010 Mar 12.

4.

Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sánchez-Font A, Garcia-Aymerich J, Coronell C, Lloreta J, Agusti AG, Gea J, Howington JA, Reed MF, Starnes SL, Harris NL, Vitucci M, Eppert BL, Motz GT, Fogel K, McGraw DW, Tichelaar JW, Orozco-Levi M.

J Clin Invest. 2009 Mar;119(3):636-49. doi: 10.1172/JCI34462. Epub 2009 Feb 9.

5.

Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.

Belting L, Hömberg N, Przewoznik M, Brenner C, Riedel T, Flatley A, Polić B, Busch DH, Röcken M, Mocikat R.

Eur J Immunol. 2015 Sep;45(9):2593-601. doi: 10.1002/eji.201445375. Epub 2015 Jul 7.

6.

Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease.

Eppert BL, Wortham BW, Flury JL, Borchers MT.

J Immunol. 2013 Feb 1;190(3):1331-40. doi: 10.4049/jimmunol.1202442. Epub 2012 Dec 21.

7.

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.

Eur J Immunol. 2003 Feb;33(2):381-91.

8.

Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Campbell TM, McSharry BP, Steain M, Slobedman B, Abendroth A.

J Virol. 2015 Aug;89(15):7932-43. doi: 10.1128/JVI.00292-15. Epub 2015 May 20.

9.

Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.

Zafirova B, Mandarić S, Antulov R, Krmpotić A, Jonsson H, Yokoyama WM, Jonjić S, Polić B.

Immunity. 2009 Aug 21;31(2):270-82. doi: 10.1016/j.immuni.2009.06.017. Epub 2009 Jul 23.

10.

Shed NKG2D ligand boosts NK cell immunity.

Narni-Mancinelli E, Vivier E.

Cell Res. 2015 Jun;25(6):651-2. doi: 10.1038/cr.2015.41. Epub 2015 Apr 7.

11.

A dual function of NKG2D ligands in NK-cell activation.

Cheney EE, Wise EL, Bui JD, Schreiber RD, Carayannopoulos LN, Spitzer D, Zafirova B, Polic B, Shaw AS, Markiewicz MA.

Eur J Immunol. 2012 Sep;42(9):2452-8. doi: 10.1002/eji.201141849. Epub 2012 Jul 27.

12.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

13.

NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).

Watanabe M, Kudo Y, Kawano M, Nakayama M, Nakamura K, Kameda M, Ebara M, Sato T, Nakamura M, Omine K, Kametani Y, Suzuki R, Ogasawara K.

Int Immunol. 2014 Nov;26(11):597-606. doi: 10.1093/intimm/dxu053. Epub 2014 May 24.

PMID:
24860119
14.

Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Bélanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP.

Blood. 2012 Jul 19;120(3):592-602. doi: 10.1182/blood-2012-02-408732. Epub 2012 Jun 1. Erratum in: Blood. 2013 Oct 3;122(14):2525.

15.

Distinct mechanisms of tumor resistance to NK killing: of mice and men.

Pardoll DM.

Immunity. 2015 Apr 21;42(4):605-6. doi: 10.1016/j.immuni.2015.04.007.

16.

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.

Deng W, Gowen BG, Zhang L, Wang L, Lau S, Iannello A, Xu J, Rovis TL, Xiong N, Raulet DH.

Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5.

17.

The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.

Beilke JN, Benjamin J, Lanier LL.

Blood. 2010 Dec 9;116(24):5208-16. doi: 10.1182/blood-2010-05-285031. Epub 2010 Aug 24.

18.

Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease Pathologies.

Wortham BW, Eppert BL, Flury JL, Garcia SM, Donica WR, Osterburg A, Joyce-Shaikh B, Cua DJ, Borchers MT.

J Immunol. 2016 Apr 15;196(8):3227-31. doi: 10.4049/jimmunol.1500978. Epub 2016 Feb 29.

19.

Influenza A virus-dependent remodeling of pulmonary clock function in a mouse model of COPD.

Sundar IK, Ahmad T, Yao H, Hwang JW, Gerloff J, Lawrence BP, Sellix MT, Rahman I.

Sci Rep. 2015 Apr 29;4:9927. doi: 10.1038/srep09927.

20.

Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Weinger JG, Plaisted WC, Maciejewski SM, Lanier LL, Walsh CM, Lane TE.

Stem Cells. 2014 Oct;32(10):2690-701. doi: 10.1002/stem.1760.

Supplemental Content

Support Center